4.8 Article

A Liquid Biopsy Signature for the Early Detection of Gastric Cancer in Patients

Related references

Note: Only part of the references are listed.
Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Medicine, General & Internal

Cancer statistics in China and United States, 2022: profiles, trends, and determinants

Changfa Xia et al.

Summary: The study compared the latest cancer profiles, trends, and determinants between China and the USA in 2022. China has a higher incidence of lung cancer, while the USA has more cases of breast cancer. Recent years have seen a significant decrease in lung and colorectal cancer rates in the USA, while liver cancer rates have slightly increased. In China, rates for stomach, liver, and esophageal cancer have decreased gradually, but colorectal cancer rates have increased for the whole population.

CHINESE MEDICAL JOURNAL (2022)

Article Medicine, General & Internal

Circulating exosomal gastric cancer-associated long noncoding RNA1 as a noninvasive biomarker for predicting chemotherapy response and prognosis of advanced gastric cancer: A multi-cohort, multi-phase study

Qiying Song et al.

Summary: This study validates the diagnostic value of circulating exosomal lncRNA-GC1 for detecting and monitoring gastric cancer and further determines its predictive role in prognosis and chemotherapy response. Circulating exosomal lncRNA-GC1 can serve as an independent prognostic predictor and outperforms the traditional AJCC stage system. Patients with low-level circulating exosomal lncRNA-GC1 benefit more from adjuvant chemotherapy after surgery.

EBIOMEDICINE (2022)

Article Gastroenterology & Hepatology

A Liquid Biopsy Signature for the Detection of Patients With Early-Onset Colorectal Cancer

Kota Nakamura et al.

Summary: A circulating miRNA signature has been developed as a potential noninvasive diagnostic tool for early-onset colorectal cancer (EOCRC), with high accuracy and clinical application potential.

GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population

Jimmy Bok Yan So et al.

Summary: A serum 12-miRNA biomarker assay was developed and validated for gastric cancer detection, showing high sensitivity and specificity in clinical studies. The assay may be a cost-effective risk assessment tool for gastric cancer screening compared to current practices.
Review Oncology

Circulating tumor cell profiling for precision oncology

Mahmoud Labib et al.

Summary: Analysis of circulating tumor cells provides valuable insights in precision oncology, revealing associations between CTCs molecular profiles and tumor response to therapy. However, current limitations hinder the widespread clinical implementation of CTCs, suggesting the need for further research and advanced technologies.

MOLECULAR ONCOLOGY (2021)

Article Oncology

Liquid biopsy enters the clinic - implementation issues and future challenges

Michail Ignatiadis et al.

Summary: The approval of liquid biopsy assays for detecting genetic alterations in plasma cell-free DNA has marked a tipping point for the clinical use of this technology, especially in patients with advanced-stage cancer. The next frontier is likely to be the systemic treatment of patients with 'ctDNA relapse' and other potential future applications include cancer screening and diagnosis.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Multidisciplinary Sciences

Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients

Yongliang Zhang et al.

Summary: The study conducted a ctDNA-based analysis on over 10,000 pan-cancer Chinese patients, revealing age-related CH variants, detection rates of ctDNA in different cancer types, and the frequencies of potential driver genes. The findings may be valuable for identifying therapeutic targets and developing combined treatment strategies.

NATURE COMMUNICATIONS (2021)

Review Oncology

Exosome-based liquid biopsies in cancer: opportunities and challenges

W. Yu et al.

Summary: Liquid biopsy in cancer research has seen significant progress, with efforts focused on utilizing circulating tumor cells, circulating tumor DNA, and extracellular vesicles like exosomes. Exosomes, as part of the intercellular communication system, carry tumor-derived materials and can serve as stable biomarkers for early detection and monitoring of cancer.

ANNALS OF ONCOLOGY (2021)

Article Oncology

Current treatment and recent progress in gastric cancer

Smita S. Joshi et al.

Summary: Gastric cancer is a common cause of cancer death worldwide, with treatment options including systemic chemotherapy, radiotherapy, surgery, immunotherapy, and targeted therapy. Classification and biomarkers for gastric cancer help in personalized therapy and identifying populations most likely to benefit from immunotherapy and targeted therapy.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Medicine, General & Internal

Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020

Wei Cao et al.

Summary: This study summarized the recent changing profiles of cancer burden worldwide and in China, revealing that breast cancer became the most diagnosed cancer globally in 2020. China accounted for 24% of newly diagnosed cases and 30% of cancer-related deaths worldwide in 2020, with a high cancer mortality rate.

CHINESE MEDICAL JOURNAL (2021)

Review Oncology

Liquid Biopsy: From Discovery to Clinical Application

Catherine Alix-Panabieres et al.

Summary: CTC and ctDNA have been recognized as promising biomarkers with various clinical applications, including early cancer detection and therapeutic monitoring. However, challenges such as standardization and validation of clinical effectiveness need to be addressed in this dynamic field of translational cancer research.

CANCER DISCOVERY (2021)

Review Oncology

Small extracellular vesicle non-coding RNAs in pancreatic cancer: molecular mechanisms and clinical implications

Moritz Reese et al.

Summary: Pancreatic cancer has a poor prognosis due to its aggressive nature, late diagnosis, and resistance to treatment. Non-coding RNAs distributed through sEVs in the tumor microenvironment play a crucial role in intercellular communication and can serve as potential biomarkers and delivery vehicles for cancer therapy.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2021)

Review Biochemistry & Molecular Biology

Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications

Xiao-Huan Tang et al.

Summary: Exosomes, a subpopulation of the tumour microenvironment (TME), are crucial for intercellular communication and are enriched with noncoding RNAs that play important roles in the tumorigenesis, progression, and drug resistance of gastric cancer (GC). Regulating exosomal ncRNAs levels could potentially serve as therapeutic targets for GC treatment.

MOLECULAR CANCER (2021)

Article Medicine, General & Internal

Global Incidence and Mortality of Gastric Cancer, 1980-2018

Martin C. S. Wong et al.

Summary: This study evaluated the incidence and mortality trends of gastric cancer globally from 1980 to 2018, showing a decrease in overall incidence and mortality rates. However, there is an increasing incidence of gastric cancer in younger populations in some countries, emphasizing the importance of preventive strategies for this age group.

JAMA NETWORK OPEN (2021)

Review Oncology

Better together: circulating tumor cell clustering in metastatic cancer

Emma Schuster et al.

Summary: CTC clusters play a crucial role in cancer, with a higher metastatic potential and unfavorable clinical outcomes compared to single CTCs. While the mechanism of CTC cluster formation is still unclear, certain cell adhesion molecules and tight junction proteins have been identified as key factors.

TRENDS IN CANCER (2021)

Review Gastroenterology & Hepatology

Burden of Gastric Cancer

Aaron P. Thrift et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Non-coding RNAs in GI cancers: from cancer hallmarks to clinical utility

Mihnea Paul Dragomir et al.

Review Pharmacology & Pharmacy

Circulating tumor DNA as an early cancer detection tool

Andrea Campos-Carrillo et al.

PHARMACOLOGY & THERAPEUTICS (2020)

Review Oncology

Liquid Biopsy-Based Biomarkers of Treatment Response and Resistance

Elaine Kilgour et al.

CANCER CELL (2020)

Article Multidisciplinary Sciences

Non-invasive early detection of cancer four years before conventional diagnosis using a blood test

Xingdong Chen et al.

NATURE COMMUNICATIONS (2020)

Review Nanoscience & Nanotechnology

Exosome: A Review of Its Classification, Isolation Techniques, Storage, Diagnostic and Targeted Therapy Applications

Yi Zhang et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)

Article Medicine, General & Internal

Gastric cancer

Elizabeth C Smyth et al.

LANCET (2020)

Review Biochemistry & Molecular Biology

Exosomes in cancer development, metastasis, and immunity

Lin Zhang et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)

Article Biochemistry & Molecular Biology

LncRNA GClnc1 promotes proliferation and invasion of bladder cancer through activation of MYC

Chengle Zhuang et al.

FASEB JOURNAL (2019)

Review Biochemistry & Molecular Biology

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA

Qianwei Ye et al.

MOLECULAR CANCER (2019)

Review Medicine, Research & Experimental

Extracellular vesicle-based drug delivery systems for cancer treatment

Sierra Walker et al.

THERANOSTICS (2019)

Article Oncology

Exosomal TRIM3 is a novel marker and therapy target for gastric cancer

Hailong Fu et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)

Article Biochemistry & Molecular Biology

Tumor-originated exosomal lncUEGC1 as a circulating biomarker for early-stage gastric cancer

Ling-Yun Lin et al.

MOLECULAR CANCER (2018)

Review Oncology

Extracellular vesicles in cancer - implications for future improvements in cancer care

Rong Xu et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Review Cell Biology

Shedding light on the cell biology of extracellular vesicles

Guillaume van Niel et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2018)

Article Biochemistry & Molecular Biology

CircRNA microarray profiling identifies a novel circulating biomarker for detection of gastric cancer

Weiwei Tang et al.

MOLECULAR CANCER (2018)

Article Biochemistry & Molecular Biology

Long non-coding RNA GClnc1 promotes tumorigenesis in osteosarcoma by inhibiting p53 signaling

Yutong Sui et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)

Article Cell Biology

Enhanced detection of circulating tumor DNA by fragment size analysis

Florent Mouliere et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Review Cell Biology

A conduit to metastasis: circulating tumor cell biology

Douglas S. Micalizzi et al.

GENES & DEVELOPMENT (2017)